Ketoprofen Extended-Release Capsules and Lanreotide Subcutaneous
Determining the interaction of Ketoprofen Extended-Release Capsules and Lanreotide Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: ketoprofen
Brand name: Oruvail, Orudis, Actron, Orudis KT
Synonyms: Ketoprofen
Generic Name: lanreotide
Brand name: Somatuline Depot
Synonyms: Lanreotide
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Ketoprofen Extended-Release Capsules-Lansoprazole
- Ketoprofen Extended-Release Capsules-Lansoprazole Delayed-Release Capsules
- Ketoprofen Extended-Release Capsules-Lansoprazole Orally Disintegrating Tablets
- Ketoprofen Extended-Release Capsules-Lansoprazole, Amoxicillin, and Clarithromycin
- Ketoprofen Extended-Release Capsules-Lanthanum
- Ketoprofen Extended-Release Capsules-Lanthanum carbonate
- Lanreotide Subcutaneous-Ketorolac
- Lanreotide Subcutaneous-Ketorolac (Systemic)
- Lanreotide Subcutaneous-Ketorolac Eye Drops (Multi-Dose Containers)
- Lanreotide Subcutaneous-Ketorolac Eye Drops (Single-Dose Containers)
- Lanreotide Subcutaneous-Ketorolac Injection
- Lanreotide Subcutaneous-Ketorolac nasal